尚荣医疗收盘上涨5.75%，滚动市盈率180.72倍，总市值40.41亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Shangrong Medical, noting its significant increase in stock price and its high PE ratio compared to industry averages [1][2] - As of August 12, Shangrong Medical's stock closed at 4.78 yuan, up 5.75%, with a rolling PE ratio of 180.72, marking a new low in 604 days and a total market capitalization of 4.041 billion yuan [1] - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Shangrong Medical at the 113th position in the industry ranking [1][2] Group 2 - In terms of financial performance, the latest quarterly report for Q1 2025 shows Shangrong Medical achieved operating revenue of 280 million yuan, a year-on-year increase of 30%, and a net profit of 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The company's sales gross margin stands at 15.27% [2] - Shangrong Medical is recognized as a national high-tech enterprise and has received numerous accolades, including over 180 patents, which contribute to its ongoing development [1]